% Expired Patents = 44.4

EPO Patents = 1

Forward Citations = 15

Loading Chart...

2 inventors (with patents filed for the assignee):

Shuling Cheng (7 out of 7 patents)

Shu-Ling Cheng (2 out of 3 patents)

Cheng Shuling (0 patent)

9 patents: Sort by Forward Citations

1. 9568474 - In situ detection of early stages and late stages HPV infection (2017-02-14),

2. 9128094 - High throughput cell-based HPV immunoassays for diagnosis and screening of HPV-associated cancers (2015-09-08),

3. 8968995 - Detection, screening, and diagnosis of HPV-associated cancers (2015-03-03),

4. 8916342 - Identification of high grade or ≧ CIN2 for early stages and late stages detection, screening, and diagnosis of human papillomavirus (HPV) and HPV-associated cancers (2014-12-23),

5. 8865162 - Monoclonal antibodies against HPV proteins (2014-10-21),

6. 8859218 - In situ detection of early stages and late stages HPV infection (2014-10-14),

7. 8278056 - Detection of early stages and late stages HPV infection (2012-10-02),

8. 7972776 - Protein chips for HPV detection (2011-07-05),

9. 7732166 - Detection method for human pappilomavirus (HPV) and its application in cervical cancer (2010-06-08),

Company Overview

Oncohealth Corporation is a leading biotechnology company specializing in innovative cancer treatments and personalized medicine. With a focus on precision oncology, Oncohealth is dedicated to developing breakthrough therapies to improve patient outcomes and quality of life. Through cutting-edge research and collaboration with top experts in the field, Oncohealth is committed to advancing the fight against cancer.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

9 Patents

#195 in Fremont, CA

#7,745 in California

#32,605 in US

Fremont, CA, United States of America

Oncohealth Corporation

Forward Citations = 15

2 inventors:

Shuling Cheng (7 out of 7 patents)

Shu-Ling Cheng (2 out of 3 patents)

Cheng Shuling (0 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Oncohealth Corporation. Retrieved from https://idiyas.com/company/oncohealth

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]